Effects of Tai Chi Exercises With Cycling in Subacute Stroke
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Oct 24, 2024
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how combining Tai Chi exercises with cycling can help people who have had a stroke. A stroke can cause serious problems with movement and feeling, making daily life difficult. Tai Chi is a gentle exercise that focuses on slow movements and mindfulness, while cycling can help strengthen the legs. Together, these activities may improve recovery for stroke survivors in the sub-acute phase, which is the period from two weeks to less than three months after the stroke.
To participate in this trial, you need to be between 50 and 65 years old and able to walk at least 10 meters, even if you need some help. You should also not have any serious visual, balance, or joint problems that could interfere with the exercises. If you are currently involved in another study or have certain medical conditions, you may not be eligible. If you join the study, you can expect to learn and practice these exercises under the guidance of a researcher to potentially improve your recovery and quality of life after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants with the age ranged between 50-65 years.
- • Participants with either gender.
- • Patients who are in the sub-acute phase (from 2 weeks to less than 3 months after onset).
- • No visual field defect.
- • No abnormality of the vestibular organs.
- • No orthopedic disease.
- • The ability to understand and perform the exercise as instructed by the researcher
- • Muscle power of at least grade three.
- • Could walk at least 10 meters with or without assistive devices.
- Exclusion Criteria:
- • Chronic stroke patient.
- • Participants with aphasia and cognitive impairment.
- • Cardiac arrhythmias
- • Any condition for which exercise is contraindicated
- • Fracture of the lower limb.
- • Participants who are currently participating in another clinical trial or research study.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Muhammad Asrar Yousaf, Mphil
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported